Prospective Randomized Trial to Compare a Twice Daily to a Once Daily Administration of the Tacrolimus in Lung Transplanted Patients.

Trial Profile

Prospective Randomized Trial to Compare a Twice Daily to a Once Daily Administration of the Tacrolimus in Lung Transplanted Patients.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Lung transplant rejection
  • Focus Therapeutic Use
  • Acronyms Advagraf
  • Most Recent Events

    • 21 Jul 2012 Actual initiation date (2 Jul 2012) added as reported by European Clinical Trials Database record.
    • 02 Jul 2012 Status changed from not yet recruiting to discontinued as reported by European Clinical Trials Database record.
    • 30 Jul 2009 Planned initiation date (Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top